-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Abbott Laboratories quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Abbott Laboratories Operating Income (Loss) for the quarter ending September 30, 2024 was $1.86B, a 12.9% increase year-over-year.
- Abbott Laboratories Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.69B, a 11.5% increase year-over-year.
- Abbott Laboratories annual Operating Income (Loss) for 2023 was $6.48B, a 22.5% decline from 2022.
- Abbott Laboratories annual Operating Income (Loss) for 2022 was $8.36B, a 0.75% decline from 2021.
- Abbott Laboratories annual Operating Income (Loss) for 2021 was $8.43B, a 57.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)